MRI Evaluation and Surgical Planning

Seminars in Breast Disease

Volumn 7, Issue 4, 2004, Pages 159-171

  Harms, Steven E ^a,b   Harms, Sally S ^c  

^a Breast Center of Northwest Arkansas   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c Harms MRI Consulting   (United States)

Author keywords

breast abnormalities; breast cancer; breast imaging; breast neoplasms; MRI

Indexed keywords

GADOLINIUM; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ADJUVANT CHEMOTHERAPY; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER DIAGNOSIS; CARCINOMA IN SITU; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ESTHETICS; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAMMOGRAPHY; MEDICAL DECISION MAKING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL MASTECTOMY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 33745103032     PISSN: 10924450     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sembd.2006.04.002     Document Type: Article

References (29)

1. Fisher B., Redmond C., Poisson R., et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 320 (1989) 822-828
2. Morrow M. Magnetic resonance imaging in breast cancer. one step forward, two steps back?. J Am Med Assoc 292 (2004) 2779-2780
3. Schmidt-Ullrich R., Wazer D.E., Tercilla O., et al. Tumor margin assessment as a guide to optimal conservation surgery and irradiation in eary stage breast carcinoma. Int J Radiat Oncol Biol Phys 17 (1989) 733-738
4. Solin L.J., Fowble B.L., Schultz D.J., et al. The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phys 21 (1991) 279-287
5. Haga S., Makita M., Shimizu T., et al. Histopathological study of local residual carcinoma after simulated lumpectomy. Surg Today 25 (1995) 329-333
6. Harms S.E., Flamig D.P., Hesley K.L., et al. MR imaging of the breast with rotating delivery of excitation off resonance. clinical experience with pathologic correlation. Radiology 187 (1993) 493-501
7. Esserman L., Hylton N., Yassa L., et al. Utility of magnetic resonance imaging in the management of breast cancer. evidence for improved preoperative staging. J Clin Oncol 17 (1999) 110-119
8. Hrung J.M., Sonnad S.S., Schwartz J.S., et al. Accuracy of MR imaging in the work-up of suspicious breast lesions. diagnostic meta-analysis. Acad Radiol 6 (1999) 387
9. Lee S.G., Orel S.G., Woo I.J., et al. MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer. a preliminary result. Radiology 226 (2003) 387-397
10. Mahfouz A.E., Sherif H., Saad A., et al. Gadolinium-enhanced MR angiography of the breast. is breast cancer associated with ipsilateral higher vascularity?. Eur Radiol 11 (2001) 965-969
11. Liberman L., Morris E.A., Kim C.M., et al. MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenol 180 (2003) 333-341
12. Berg W.A., Gutierrez L., NessAiver M.S., et al. Diagnostic accuracy of mammography, clinical examination US and MR imaging in preoperative assessment of breast cancer. Radiology 233 (2004) 830-849
13. Klimberg V.S., Harms S., and Korourian S. Assessing margin status. Surg Oncol 8 (1999) 77-84
14. Soderstrom C.E., Harms S.E., Farrell Jr. R.S., et al. Detection with MR imaging of residual tumor in the breast soon after surgery. AJR Am J Roentgenol 168 (1997) 485-488
15. Frei K.A., Kinkel K., Bonel H.M., et al. MR imaging of the breast in patients with positive margins after lumpectomy. influence of the time interval between lumpectomy and MR imaging. AJR Am J Roentgenol 175 (2000) 1577-1584
16. Dershaw D.D., Abramson A., and Kinne D.W. Ductal carcinoma in situ. mammographic findings and clinical implications. Radiology 170 (1989) 411-415
17. Soderstrom C.E., Harms S.E., Copit D.S., et al. 3D RODEO breast MRI of lesions containing ductal carcinoma in situ. Radiology 201 (1996) 427-432
18. Orel S.G., Mendonca M.H., Reynolds C., et al. MR imaging of ductal carcinoma in situ. Radiology 202 (1997) 413-420
19. Menell J.H., Morris E.A., Dershaw D.D., et al. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J 11 (2005) 382-390
20. Harms S.E. The use of breast magnetic resonance imaging in ductal carcinoma in situ. Breast J 11 (2005) 379-381
21. Kuhl C.K., Mielcareck P., Klaschik S., et al. Dynamic breast MR imaging. are signal intensity time course data useful for differential diagnosis of enhancing lesions?. Radiology 211 (1999) 101-110
22. Rodenko G.N., Harms S.E., Pruneda J.M., et al. MR imaging in the management before surgery of lobular carcinoma of the breast. correlation with pathology. AJR Am J Roentgenol 167 (1996) 1415-1419
23. Weinstein S.P., Orel S.G., Heller R., et al. MR imaging of the breast in patients with invasive lobular carcinoma. AJR Am J Roentgenol 176 (2001) 399-406
24. Avril N., Rose C.A., Schelling M., et al. Breast imaging with positron emission tomography fluorine-18 fluorodeoxyglucose. use and limitations. J Clin Oncol 18 (2000) 3495-3502
25. Abraham D.C., Jones R.C., Jones S.E., et al. Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging. Cancer 78 (1996) 91-100
26. Rieber A., Brambs H.J., Gabelmann A., et al. Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy. Eur Radiol 12 (2002) 1711-1719
27. Weatherall P.T., Evans G.F., Metzger G.J., et al. MRI vs. histologic measurement of breast cancer following chemotherapy. comparison with x-ray mammography and palpation. J Magn Reson Imaging 13 (2001) 868-875
28. Anzai Y., Piccoli C.W., Outwater E.K., et al. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging. phase III safety and efficacy study. Radiology 228 (2003) 777-788
29. Harisinghani M.G., Barentsz J., Hahn P.F., et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348 (2003) 2491-2499